OCULOXIN® is a unique blend of standardized extracts from Vaccinium myrtillus L., Aronia Melanocarpa, and Lonicera caerulea var. Kamtschatica, designed to enhance visual health. This innovative formula features a synergistic mix of polyphenols, including anthocyanins, and iridoids, optimized to improve various visual parameters. Sourced from local, controlled plantations in Poland, OCULOXIN® guarantees high-quality extracts. The production involves double standardization, ensuring anthocyanins content of at least 25% and iridoids of no less than 2%. Recommended for those experiencing eye strain from screens, presbyopia, early diabetic retinopathy, or asthenopia, the suggested dose is 150-200 mg twice daily.
Home » OCULOXIN®: A Synergistic Blend for Enhanced Visual Health
OCULOXIN®: A Synergistic Blend for Enhanced Visual Health
Facebook
Twitter
LinkedIn
Email
WhatsApp
Facebook
Twitter
LinkedIn
Email
WhatsApp
Related Shorts
Nucleotide-Rich Meals and Uric Acid
September 29, 2026
Cumin Seed Extract and Its Wound-Healing Potential
September 29, 2026
Beetroot Juice and Heart Health After Menopause
September 21, 2026
Puerarin and the Gut–Liver–Brain Axis in Depression
September 21, 2026
Object Recognition Test (ORT): A Versatile Tool for Memory Research in Mice
September 14, 2026
Yeast Protein on Gut Barrier Function and Inflammation
September 14, 2026